# Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to Hysteroscopy

> **NCT00925938** · PHASE2 · COMPLETED · sponsor: **Ferring Pharmaceuticals** · enrollment: 51 (actual)

## Conditions studied

- Cervical Priming

## Interventions

- **DRUG:** misoprostol
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT00925938
- **Lead sponsor:** Ferring Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2014-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00925938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00925938, "Efficacy and Safety Study of the Misoprostol Vaginal Priming Insert (MVPI) Prior to Hysteroscopy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00925938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*